ARTICLE | Company News
Myriad, BeiGene deal
April 13, 2017 11:13 PM UTC
BeiGene and Myriad Genetics will develop a companion diagnostic to support development of BeiGene's BGB-290 using Myriad's myChoice Homologous Recombination Deficiency (HRD) and BRACAnalysis CDx tests...